✦ LIBER ✦

What motivates Parkinson’s disease patients to enter clinical trials?

✍ Scribed by Anabela Valadas; Miguel Coelho; Tiago Mestre; Leonor Correia Guedes; Maria Finisterra; Ana Noronha; Mário M. Rosa; Cristina Sampaio; Joaquim J. Ferreira

Book ID: 116821007
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 271 KB
Volume: 17
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2011.05.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene therapy for Parkinson's disease set

Gene therapy for Parkinson's disease set to enter phase I trials

✍ James Butcher 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 285 KB

Patient Diaries As a Clinical Endpoint i

Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials

✍ Spyridon (Spyros) Papapetropoulos 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

3.12.1 WHAT ARE THE PITFALLS OF CLINICAL

3.12.1 WHAT ARE THE PITFALLS OF CLINICAL TRIALS IN PARKINSON'S DISEASE?

✍ A.D. Korczyn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Discontinuation of ropinirole and pramip

Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials

✍ Maurits E. L. Arbouw; Kris L. L. Movig; Henk-Jan Guchelaar; Petra J. E. Poels; J 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 149 KB

Gene Therapy Approaches to Parkinson's D

Gene Therapy Approaches to Parkinson's Disease: Preclinical to Clinical Trials, or What Steps to Take to Get There from Here?

✍ D.Eugene Redmond Jr. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Why are (or are not) patients given the

Why are (or are not) patients given the option to enter clinical trials?

✍ G. Ross Langley; Heather J. Sutherland; Samuel Wong; Salomon Minkin; Hilary A. L 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 627 KB